Single agent for adjuvant treatment in patients w/ Dukes C colon cancer who have undergone complete resection of the primary tumor when treatment w/ fluoropyrimidine therapy alone is preferred. Treatment of patients w/ metastatic breast cancer after failure of prior anthracycline-containing chemotherapy.
Dosage
1,250 mg/m2 bid for 2 wk followed by 1-wk rest period given as 3-wk cycles. Combination w/ docetaxel: 1,250 mg/m2 bid for 2 wk followed by 1-wk rest period + docetaxel 75 mg/m2 1 hr IV infusion every 3 wk.
You are now entering the prescription medicines section of this website. This page is intended exclusively for healthcare professionals and patients who have been prescribed the relevant medication. By continuing, you confirm that you meet this criteria.
Please consult your physician or other qualified healthcare providers before taking any prescription medicines mentioned here. The information provided is for educational and informational purposes only and should not be considered a substitute for professional medical advice. Always read the product packaging and labels carefully before use.
